Evidence map›Paper›PMID 17563730›Full record

ArticleMolecular vision2007

Evaluation of AC(n) and C(-106)T polymorphisms of the aldose reductase gene in Brazilian patients with DM1 and susceptibility to diabetic retinopathy.

Flávio Richeti, Renata Maria Noronha, Ricardo Temudo Lessa Waetge, José Paulo Cabral de Vasconcellos, Osías Francisco de Souza, Bianca Kneipp, Nilma Assis, Mylene Neves Rocha, Luís Eduardo Procópio Calliari, Carlos Alberto Longui and 2 more

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Update on genetics and diabetic retinopathy.Clinical ophthalmology (Auckland, N.Z.) · 2015
    Review
  10. Human genetics of diabetic retinopathy.Journal of endocrinological investigation · 2014
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. The role of genetics in susceptibility to diabetic retinopathy.International ophthalmology clinics · 2009
    Review
  17. Genetic susceptibility of diabetic retinopathy.Current diabetes reports · 2008
    Review
  18. Article
  19. An eye on sickle cell retinopathy.Revista brasileira de hematologia e hemoterapia
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Flávio RichetiLaboratory of Molecular Medicine, Department of Physiology, Faculty of Medical Sciences, Irmandade da Santa Casa de Misericórdia de São Paulo, Brazil
Renata Maria Noronha
Ricardo Temudo Lessa Waetge
José Paulo Cabral de Vasconcellos
Osías Francisco de Souza
Bianca Kneipp
Nilma Assis
Mylene Neves Rocha
Luís Eduardo Procópio Calliari
Carlos Alberto Longui
Osmar Monte
Monica Barbosa de Melo
Irmandade da Santa Casa de Misericórdia de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDiabetic retinopathy (DR) is one of the most important microvascular complications in both type 1 and type 2 diabetes. In Brazil, its proliferative form is the second cause of irreversible blindness among adults of working age. Despite the strong association of DR with disease duration and degree of chronic hyperglycemia, genetic predisposition has been recognized as a possible trigger in the development of this complication. Recent studies have demonstrated that the development of DR in patients with type 1 diabetes is associated with the occurrence of polymorphisms at the 5'-end of the aldose reductase gene (ALR2). There are no reports investigating these polymorphisms in type 1 diabetes Brazilian patients. The aim of this study was to investigate the relationship between the AC(n) repeat and C(-106)T polymorphisms of the ALR2 gene with the susceptibility to the development of DR in Brazilian patients with type 1 diabetes.

methodsWe selected 64 patients who had diabetes for at least 10 years from Santa Casa de São Paulo and State University of Campinas. The study group was divided into the following: Group 1, patients with no evidence of diabetic retinopathy; group 2, patients with nonproliferative diabetic retinopathy (NPDR); and group 3, patients with proliferative diabetic retinopathy (PDR), confirmed by fundoscopy. The AC(n) microsatellite region was evaluated through polymerase chain reaction (PCR) and automated genotyping and the C(-106)T substitution through polymerase chain reaction/restriction fragment length polymorphism (RFLP).

resultsWhen each allele of the AC(n) polymorphism was evaluated, the Z allele (24 repeats) was significantly associated with the development of PDR (p=0.014). The C allele of the C(-106)T substitution wasn't associated with the susceptibility to this microvascular complication (p=0.153). When the Z and C allele were concomitantly evaluated regarding their presence or absence a positive correlation was observed for the presence of both alleles and the development of PDR.

conclusionsIn our sample of Brazilian patients with type 1 diabetes, the presence of the AC(n) polymorphism Z allele may be considered a risk factor for the development of PDR. The C allele of the C(-106)T polymorphism, in association with the Z allele, also increased the risk for the development of PDR, but when it was analyzed by itself there was no association with the complication.

Indexed as

Genetic Predisposition to DiseasePolymorphism, GeneticAdolescentAdultAldehyde ReductaseBrazilChildCytosineDiabetes Mellitus, Type 1Diabetic RetinopathyFemaleHaplotypesHumansMaleMiddle AgedRepetitive Sequences, Nucleic AcidAKR1B1 protein, humanAldehyde ReductaseCytosineThymine

Identifiers

PMID17563730
PMCPMC2765471
OpenAlexW280568639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.